T2 Biosystems, Inc. Net Income (Loss) Available to Common Stockholders, Basic
T2 Biosystems, Inc. reported Net Income (Loss) Available to Common Stockholders, Basic of -$50.08 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-04-01.
Discontinued › Income Statement
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic · last filed 2024-04-01
- T2 Biosystems, Inc. net income (loss) available to common stockholders, basic for the quarter ending 2023-12-31 was -$10.34M.
- T2 Biosystems, Inc. net income (loss) available to common stockholders, basic for the quarter ending 2023-09-30 was -$15.43M.
- T2 Biosystems, Inc. net income (loss) available to common stockholders, basic for the quarter ending 2022-12-31 was -$10.10M.
- T2 Biosystems, Inc. net income (loss) available to common stockholders, basic for the quarter ending 2022-09-30 was -$17.70M.
- T2 Biosystems, Inc. net income (loss) available to common stockholders, basic for fiscal 2023 was -$50.08M.
- T2 Biosystems, Inc. net income (loss) available to common stockholders, basic for fiscal 2022 was -$62.33M.
- T2 Biosystems, Inc. net income (loss) available to common stockholders, basic for fiscal 2021 was -$49.24M.
- T2 Biosystems, Inc. net income (loss) available to common stockholders, basic for fiscal 2016 was -$54.80M.
| Period end | Net Income (Loss) Available to Common Stockholders, Basic 3 month | Net Income (Loss) Available to Common Stockholders, Basic 6 month | Net Income (Loss) Available to Common Stockholders, Basic 9 month | Net Income (Loss) Available to Common Stockholders, Basic 12 month |
|---|---|---|---|---|
| 2023-12-31 | -$10.34M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | -$25.77M derived: sum of 2 quarters · filed 2024-04-01 | -$50.08M 10-K · filed 2024-04-01 | |
| 2023-09-30 | -$15.43M 10-Q · filed 2023-11-15 | -$39.74M 10-Q · filed 2023-11-15 | ||
| 2022-12-31 | -$10.10M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | -$27.80M derived: sum of 2 quarters · filed 2024-04-01 | -$62.33M 10-K · filed 2024-04-01 | |
| 2022-09-30 | -$17.70M 10-Q · filed 2023-11-15 | -$52.23M 10-Q · filed 2023-11-15 | ||
| 2021-12-31 | -$12.14M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$26.11M derived: sum of 2 quarters · filed 2023-03-31 | -$49.24M 10-K · filed 2023-03-31 | |
| 2021-09-30 | -$13.96M 10-Q · filed 2022-11-14 | -$37.10M 10-Q · filed 2022-11-14 | ||
| 2016-12-31 | -$14.55M 10-K · filed 2017-03-15 | -$27.33M derived: sum of 2 quarters · filed 2017-03-15 | -$41.38M derived: sum of 3 quarters · filed 2017-03-15 | -$54.80M 10-K · filed 2017-03-15 |
| 2016-09-30 | -$12.78M 10-K · filed 2017-03-15 | -$26.83M derived: sum of 2 quarters · filed 2017-03-15 | -$40.26M derived: sum of 3 quarters · filed 2017-03-15 | -$52.29M derived: sum of 4 quarters · filed 2017-03-15 |
| 2016-06-30 | -$14.05M 10-K · filed 2017-03-15 | -$27.47M derived: sum of 2 quarters · filed 2017-03-15 | -$39.50M derived: sum of 3 quarters · filed 2017-03-15 | -$51.15M derived: sum of 4 quarters · filed 2017-03-15 |
| 2016-03-31 | -$13.43M 10-K · filed 2017-03-15 | -$25.46M derived: sum of 2 quarters · filed 2017-03-15 | -$37.10M derived: sum of 3 quarters · filed 2017-03-15 | -$48.10M derived: sum of 4 quarters · filed 2017-03-15 |
| 2015-12-31 | -$12.03M 10-K · filed 2017-03-15 | -$23.68M derived: sum of 2 quarters · filed 2017-03-15 | -$34.67M derived: sum of 3 quarters · filed 2017-03-15 | -$45.29M 10-K · filed 2017-03-15 |
| 2015-09-30 | -$11.64M 10-K · filed 2017-03-15 | -$22.64M derived: sum of 2 quarters · filed 2017-03-15 | -$33.26M 10-Q · filed 2015-11-04 | -$42.33M derived: sum of 4 quarters · filed 2017-03-15 |
| 2015-06-30 | -$10.99M 10-K · filed 2017-03-15 | -$21.61M 10-Q · filed 2015-08-05 | -$30.69M derived: sum of 3 quarters · filed 2017-03-15 | -$39.54M derived: sum of 4 quarters · filed 2017-03-15 |
| 2015-03-31 | -$10.62M 10-K · filed 2017-03-15 | -$19.70M derived: sum of 2 quarters · filed 2017-03-15 | -$28.54M derived: sum of 3 quarters · filed 2017-03-15 | -$37.75M derived: sum of 4 quarters · filed 2017-03-15 |
| 2014-12-31 | -$9.08M 10-K · filed 2016-03-09 | -$17.93M derived: sum of 2 quarters · filed 2016-03-09 | -$27.13M derived: sum of 3 quarters · filed 2016-03-09 | -$35.96M 10-K · filed 2017-03-15 |
| 2014-09-30 | -$8.85M 10-K · filed 2016-03-09 | -$18.06M derived: sum of 2 quarters · filed 2016-03-09 | -$26.89M 10-Q · filed 2015-11-04 | -$35.17M derived: sum of 4 quarters · filed 2016-03-09 |
| 2014-06-30 | -$9.21M 10-K · filed 2016-03-09 | -$18.04M 10-Q · filed 2015-08-05 | -$26.32M derived: sum of 3 quarters · filed 2016-03-09 | -$32.87M derived: sum of 4 quarters · filed 2016-03-09 |
| 2014-03-31 | -$8.83M 10-K · filed 2016-03-09 | -$17.11M derived: sum of 2 quarters · filed 2016-03-09 | -$23.66M derived: sum of 3 quarters · filed 2016-03-09 | -$30.59M derived: sum of 4 quarters · filed 2016-03-09 |
| 2013-12-31 | -$8.28M 10-K · filed 2015-03-04 | -$14.84M derived: sum of 2 quarters · filed 2015-03-04 | -$21.76M derived: sum of 3 quarters · filed 2015-03-04 | -$27.52M 10-K · filed 2016-03-09 |
| 2013-09-30 | -$6.55M 10-K · filed 2015-03-04 | -$13.48M derived: sum of 2 quarters · filed 2015-03-04 | -$19.24M 10-Q · filed 2014-11-05 | |
| 2013-06-30 | -$6.92M 10-K · filed 2015-03-04 | -$12.68M 10-Q · filed 2014-09-19 | ||
| 2013-03-31 | -$5.76M 10-K · filed 2015-03-04 | |||
| 2012-12-31 | -$18.87M 10-K · filed 2015-03-04 |